{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:29:16Z","timestamp":1767173356370,"version":"build-2238731810"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91642109"],"award-info":[{"award-number":["91642109"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"State Education Ministry of China","award":["69485-a"],"award-info":[{"award-number":["69485-a"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12882-018-1165-1","type":"journal-article","created":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T09:38:31Z","timestamp":1544607511000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The elevated levels of urinary angiotensinogen are correlated with the severity of idiopathic membranous nephropathy"],"prefix":"10.1186","volume":"19","author":[{"given":"Ziyong","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyuan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3713-4737","authenticated-orcid":false,"given":"Danxia","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,12]]},"reference":[{"issue":"1","key":"1165_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000484717","volume":"4","author":"JH Hou","year":"2018","unstructured":"Hou JH, Zhu HX, Zhou ML, Le WB, Zeng CH, Liang SS, et al. Changes in the Spectrum of kidney diseases: an analysis of 40,759 biopsy-proven cases from 2003 to 2014 in China. Kidney Dis (Basel). 2018;4(1):10\u20139.","journal-title":"Kidney Dis (Basel)"},{"issue":"12","key":"1165_CR2","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.2215\/CJN.04020411","volume":"6","author":"JA Brand van den","year":"2011","unstructured":"van den Brand JA, Hofstra JM, Wetzels JF. Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 2011;6(12):2846\u201353.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"1165_CR3","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1681\/ASN.2013020185","volume":"25","author":"JA Brand van den","year":"2014","unstructured":"van den Brand JA, van Dijk PR, Hofstra JM, Wetzels JF. Long-term outcomes in idiopathic membranous nephropathy using a restrictive treatment strategy. J Am Soc Nephrol. 2014;25(1):150\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"1165_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/kisup.2012.9","volume":"2","author":"KDIGO","year":"2012","unstructured":"KDIGO. Kidney Disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis. Kidney inter. Suppl. 2012;2:139\u2013274.","journal-title":"Kidney inter. Suppl."},{"issue":"3","key":"1165_CR5","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/ki.1997.127","volume":"51","author":"DC Cattran","year":"1997","unstructured":"Cattran DC, Pei Y, Greenwood CM, Ponticelli C, Passerini P, Honkanen E. Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications. Kidney Int. 1997;51(3):901\u20137.","journal-title":"Kidney Int"},{"issue":"11","key":"1165_CR6","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1093\/ndt\/17.11.1890","volume":"17","author":"C Bazzi","year":"2002","unstructured":"Bazzi C, Petrini C, Rizza V, Arrigo G, Napodano P, Paparella M, et al. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol Dial Transplant. 2002;17(11):1890\u20136.","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"1165_CR7","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1093\/ndt\/12.12.2562","volume":"12","author":"E Honkanen","year":"1997","unstructured":"Honkanen E, Teppo AM, Tornroth T, Groop PH, Gronhagen-Riska C. Urinary transforming growth factor-beta 1 in membranous glomerulonephritis. Nephrol Dial Transplant. 1997;12(12):2562\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"1165_CR8","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1038\/ki.1997.480","volume":"52","author":"M Ruiz-Ortega","year":"1997","unstructured":"Ruiz-Ortega M, Egido J. Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int. 1997;52(6):1497\u2013510.","journal-title":"Kidney Int"},{"issue":"3","key":"1165_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1124\/pr.59.3.3","volume":"59","author":"H Kobori","year":"2007","unstructured":"Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007;59(3):251\u201387.","journal-title":"Pharmacol Rev"},{"issue":"7","key":"1165_CR10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/hr.2016.17","volume":"39","author":"H Lu","year":"2016","unstructured":"Lu H, Cassis LA, Kooi CW, Daugherty A. Structure and functions of angiotensinogen. Hypertens Res. 2016;39(7):492\u2013500.","journal-title":"Hypertens Res"},{"issue":"4","key":"1165_CR11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1159\/000286037","volume":"31","author":"M Urushihara","year":"2010","unstructured":"Urushihara M, Kondo S, Kagami S, Kobori H. Urinary angiotensinogen accurately reflects intrarenal renin-angiotensin system activity. Am J Nephrol. 2010;31(4):318\u201325.","journal-title":"Am J Nephrol"},{"issue":"8","key":"1165_CR12","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s00467-008-0801-6","volume":"23","author":"M Takamatsu","year":"2008","unstructured":"Takamatsu M, Urushihara M, Kondo S, Shimizu M, Morioka T, Oite T, et al. Glomerular angiotensinogen protein is enhanced in pediatric IgA nephropathy. Pediatr Nephrol. 2008;23(8):1257\u201367.","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"1165_CR13","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/MAJ.0b013e3181b90c25","volume":"338","author":"T Saito","year":"2009","unstructured":"Saito T, Urushihara M, Kotani Y, Kagami S, Kobori H. Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes. Am J Med Sci. 2009;338(6):478\u201380.","journal-title":"Am J Med Sci"},{"issue":"4","key":"1165_CR14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/ckj\/sfu059","volume":"7","author":"B Satirapoj","year":"2014","unstructured":"Satirapoj B, Siritaweesuk N, Supasyndh O. Urinary angiotensinogen as a potential biomarker of diabetic nephropathy. Clin Kidney J. 2014;7(4):354\u201360.","journal-title":"Clin Kidney J"},{"issue":"5","key":"1165_CR15","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/s10157-011-0475-4","volume":"15","author":"YG Kim","year":"2011","unstructured":"Kim YG, Song SB, Lee SH, Moon JY, Jeong KH, Lee TW, et al. Urinary angiotensinogen as a predictive marker in patients with immunoglobulin a nephropathy. Clin Exp Nephrol. 2011;15(5):720\u20136.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"1165_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/ndt\/gfq371","volume":"26","author":"A Nishiyama","year":"2011","unstructured":"Nishiyama A, Konishi Y, Ohashi N, Morikawa T, Urushihara M, Maeda I, et al. Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy. Nephrol Dial Transplant. 2011;26(1):170\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"1165_CR17","doi-asserted-by":"crossref","unstructured":"Mezzano SA, Aros CA, Droguett A, Burgos ME, Ardiles LG, Flores CA, et al. Renal angiotensin II up-regulation and myofibroblast activation in human membranous nephropathy. Kidney Int. 2003;64(s86):S39\u201345.","DOI":"10.1046\/j.1523-1755.64.s86.8.x"},{"issue":"5","key":"1165_CR18","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1159\/000168484","volume":"29","author":"Z Tang","year":"2009","unstructured":"Tang Z, Cheng LT, Li HY, Wang T. Serum uric acid and endothelial dysfunction in continuous ambulatory peritoneal dialysis patients. Am J Nephrol. 2009;29(5):368\u201373.","journal-title":"Am J Nephrol"},{"key":"1165_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"DC Cattran","year":"2013","unstructured":"Cattran DC, Feehally J, Terence Cook H, et al. Kidney Disease: Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and Management of Chronic Kidney Disease. Kidney inter.Suppl. 2013;3:1\u2013150.","journal-title":"Kidney inter.Suppl."},{"issue":"6","key":"1165_CR20","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.2215\/CJN.08880813","volume":"9","author":"JA Brand van den","year":"2014","unstructured":"van den Brand JA, van Dijk PR, Hofstra JM, Wetzels JF. Cancer risk after cyclophosphamide treatment in idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 2014;9(6):1066\u201373.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"1165_CR21","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.2215\/CJN.00670112","volume":"7","author":"JA Brand van den","year":"2012","unstructured":"van den Brand JA, Hofstra JM, Wetzels JF. Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 2012;7(8):1242\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"1165_CR22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12882-017-0525-6","volume":"18","author":"H Huh","year":"2017","unstructured":"Huh H, Lee H, Lee JP, Kim DK, Oh S, Oh YK, et al. Factors affecting the long-term outcomes of idiopathic membranous nephropathy. BMC Nephrol. 2017;18(1):104.","journal-title":"BMC Nephrol"},{"issue":"1","key":"1165_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12882-017-0615-5","volume":"18","author":"S Gupta","year":"2017","unstructured":"Gupta S, Connolly J, Pepper RJ, Walsh SB, Yaqoob MM, Kleta R, et al. Membranous nephropathy: a retrospective observational study of membranous nephropathy in north east and Central London. BMC Nephrol. 2017;18(1):201.","journal-title":"BMC Nephrol"},{"issue":"5","key":"1165_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jash.2008.04.008","volume":"2","author":"H Kobori","year":"2008","unstructured":"Kobori H, Ohashi N, Katsurada A, Miyata K, Satou R, Saito T, et al. Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases. J Am Soc Hypertens. 2008;2(5):349\u201354.","journal-title":"J Am Soc Hypertens"},{"issue":"5","key":"1165_CR25","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.trsl.2014.05.009","volume":"164","author":"HR Jang","year":"2014","unstructured":"Jang HR, Jeon J, Park JH, Lee JE, Huh W, Oh HY, et al. Clinical relevance of urinary angiotensinogen and renin as potential biomarkers in patients with overt proteinuria. Transl Res. 2014;164(5):400\u201310.","journal-title":"Transl Res"},{"issue":"5","key":"1165_CR26","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1681\/ASN.2006060554","volume":"18","author":"T Yamamoto","year":"2007","unstructured":"Yamamoto T, Nakagawa T, Suzuki H, Ohashi N, Fukasawa H, Fujigaki Y, et al. Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. J Am Soc Nephrol. 2007;18(5):1558\u201365.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1165_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck Jr","year":"2009","unstructured":"Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11\u201321.","journal-title":"N Engl J Med"},{"issue":"2","key":"1165_CR28","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/cei.12675","volume":"183","author":"R Bertelli","year":"2016","unstructured":"Bertelli R, Bonanni A, Di Donato A, Cioni M, Ravani P, Ghiggeri GM. Regulatory T cells and minimal change nephropathy: in the midst of a complex network. Clin Exp Immunol. 2016;183(2):166\u201374.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"1165_CR29","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.clim.2011.02.018","volume":"139","author":"LL Liu","year":"2011","unstructured":"Liu LL, Qin Y, Cai JF, Wang HY, Tao JL, Li H, et al. Th17\/Treg imbalance in adult patients with minimal change nephrotic syndrome. Clin Immunol. 2011;139(3):314\u201320.","journal-title":"Clin Immunol"},{"issue":"6","key":"1165_CR30","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00467-009-1119-8","volume":"24","author":"Y Hashimura","year":"2009","unstructured":"Hashimura Y, Nozu K, Kanegane H, Miyawaki T, Hayakawa A, Yoshikawa N, et al. Minimal change nephrotic syndrome associated with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Pediatr Nephrol. 2009;24(6):1181\u20136.","journal-title":"Pediatr Nephrol"}],"updated-by":[{"DOI":"10.1186\/s12882-019-1229-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:00:00Z","timestamp":1550016000000}}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1165-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-018-1165-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1165-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T19:15:10Z","timestamp":1576091710000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-018-1165-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1165"],"URL":"https:\/\/doi.org\/10.1186\/s12882-018-1165-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"5 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Following publication of the original article [1], it was reported that, due to a typesetting mistake, the three tables and two figures for this article were included as an Additional file instead of in the body of the article. The original publication of this article has been updated to correct this.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol of this study was approved by Peking University Third Hospital Medical Science Research Ethics Committee (IRB00006761-M2018134). All participants gave written informed consents which were obtained before the initial collection of urine samples.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"357"}}